Kunkel Lori Anne

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2026-06-09	2026-06-05	Enliven Therapeutics Inc (ELVN)	PlS Planned sale	46,121 +46.4% 69.39 US$2,942,895	46,121 +46.4%	69.39	US$2,942,895
2026-06-09	2026-06-05	Enliven Therapeutics Inc (ELVN)	PlS Planned sale	83,727 +20.6% 493.56 US$2,090,515	83,727 +20.6%	493.56	US$2,090,515
2026-06-09	2026-06-05	Enliven Therapeutics Inc (ELVN)	PlS Planned sale	50,313 -21.7% 193.94 US$2,662,870	50,313 -21.7%	193.94	US$2,662,870
2026-06-05	2026-06-05	Enliven Therapeutics Inc (ELVN)	PrS Proposed sale	20,000 35.49 US$709,800	20,000	35.49	US$709,800
2026-06-05	2026-06-05	Enliven Therapeutics Inc (ELVN)	PrS Proposed sale	20,000 35.49 US$709,800	20,000	35.49	US$709,800
2019-01-25	2019-01-23	Curis Inc (CRIS)	PlS Planned sale	14,800 -40.0% 1.05 US$15,581	14,800 -40.0%	1.05	US$15,581